v3.26.3
Condensed consolidated statements of operations and comprehensive loss - USD ($)
$ in Thousands
3 Months Ended 9 Months Ended
Sep. 30, 2026
Sep. 30, 2025
Sep. 30, 2026
Sep. 30, 2025
Operating expenses        
Research and development $ 84,667 $ 26,994 $ 256,601 $ 56,645
General and administrative 21,669 13,115 55,768 34,572
Total operating expenses 106,336 40,109 312,369 91,217
Loss from operations (106,336) (40,109) (312,369) (91,217)
Other Nonoperating Income (Expense) [Abstract]        
Interest income 10,611 2,251 26,321 6,052
Other income (expense), net 60 (1,765) 211 (1,388)
Total other income 10,671 486 26,532 4,664
Net loss (95,665) (39,623) (285,837) (86,553)
Other comprehensive loss        
Unrealized (loss) gain (1,943) 56 (3,966) 24
Comprehensive loss $ (97,608) $ (39,567) $ (289,803) $ (86,529)
Net loss per share attributable to common stockholders - basic $ (0.74) $ (39,623) $ (3.68) $ (86,553)
Net loss per share attributable to common stockholders - diluted $ (0.74) $ (39,623) $ (3.68) $ (86,553)
Weighted-average common stock outstanding - basic 129,653,008 1 77,685,234 1
Weighted-average common stock outstanding - diluted 129,653,008 1 77,685,234 1